Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - andrea facciabene
Tumor mitochondria vaccine for the treatment of cancer
Problem: Progression in cancer immunotherapy has been rapid with a number of products currently available and many others in late stage clinical development. However, clinical response to immunotherapies is variable and dependent on cancer types as well as specific characteristics or genetic mutations within a patient’s individual tumor. There...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by